162 related articles for article (PubMed ID: 35347342)
1. Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis.
Zeng J; Wang Z; Yang XJ
Eur J Clin Pharmacol; 2022 Jul; 78(7):1069-1077. PubMed ID: 35347342
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
Ma C; Guizzetti L; Panaccione R; Fedorak RN; Pai RK; Parker CE; Nguyen TM; Khanna R; Vande Casteele N; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
Aliment Pharmacol Ther; 2018 Jun; 47(12):1578-1596. PubMed ID: 29696670
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
[TBL] [Abstract][Full Text] [Related]
4. Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
Youssef M; Dong K; Lee SJ; Narula N
Inflamm Bowel Dis; 2024 Jan; 30(1):125-131. PubMed ID: 36753516
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Sedano R; Hogan M; Nguyen TM; Chang J; Zou GY; Macdonald JK; Vande Casteele N; Hanzel J; Crowley E; Battat R; Dulai PS; Singh S; D'Haens G; Sandborn W; Feagan BG; Ma C; Jairath V
J Crohns Colitis; 2022 Feb; 16(2):224-243. PubMed ID: 34309658
[TBL] [Abstract][Full Text] [Related]
6. Etrolizumab for induction of remission in ulcerative colitis.
Rosenfeld G; Parker CE; MacDonald JK; Bressler B
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011661. PubMed ID: 26630451
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis.
Magro F; Estevinho MM; Dias CC; Correia L; Lago P; Ministro P; Portela F; Feakins R; Danese S; Peyrin-Biroulet L
J Crohns Colitis; 2021 Apr; 15(4):551-566. PubMed ID: 32898223
[TBL] [Abstract][Full Text] [Related]
9. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
[TBL] [Abstract][Full Text] [Related]
10. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
[TBL] [Abstract][Full Text] [Related]
11. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Battat R; Duijvestein M; Guizzetti L; Choudhary D; Boland BS; Dulai PS; Parker CE; Nguyen TM; Singh S; Vande Casteele N; Pai RK; Feagan BG; Sandborn WJ; Jairath V
Am J Gastroenterol; 2019 May; 114(5):733-745. PubMed ID: 30694863
[TBL] [Abstract][Full Text] [Related]
12. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
13. Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
Macaluso FS; Maida M; Ventimiglia M; Renna S; Cottone M; Orlando A
Inflamm Bowel Dis; 2019 May; 25(6):987-997. PubMed ID: 30590590
[TBL] [Abstract][Full Text] [Related]
14. Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis.
Zeng J; Lv L; Mei ZC
J Gastroenterol Hepatol; 2017 Mar; 32(3):558-566. PubMed ID: 27699863
[TBL] [Abstract][Full Text] [Related]
15. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L; Hart A; Bossuyt P; Long M; Allez M; Juillerat P; Armuzzi A; Loftus EV; Ostad-Saffari E; Scalori A; Oh YS; Tole S; Chai A; Pulley J; Lacey S; Sandborn WJ;
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):128-140. PubMed ID: 34798039
[TBL] [Abstract][Full Text] [Related]
16. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
Cochrane Database Syst Rev; 2014 Aug; (8):CD007571. PubMed ID: 25105240
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for induction of remission in ulcerative colitis.
Chande N; Wang Y; MacDonald JK; McDonald JW
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
[TBL] [Abstract][Full Text] [Related]
18. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK; Wang JJ
Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the placebo response in ulcerative colitis.
Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
[TBL] [Abstract][Full Text] [Related]
20. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
